Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
3,446,049
-
Shares change
-
+28,541
-
Total reported value, excl. options
-
$13,790,459
-
Value change
-
+$111,471
-
Put/Call ratio
-
25%
-
Number of buys
-
16
-
Number of sells
-
-11
-
Price
-
$4
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2023
43 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2023.
XBiotech Inc. - Common Shares, no par value (XBIT) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,446,049 shares
of 33,289,095 outstanding shares and own 10.35% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (881,511 shares), MILLENNIUM MANAGEMENT LLC (795,726 shares), BlackRock Inc. (278,159 shares), CREDIT SUISSE AG/ (248,270 shares), GEODE CAPITAL MANAGEMENT, LLC (192,588 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (144,593 shares), MORGAN STANLEY (110,517 shares), NORTHERN TRUST CORP (79,027 shares), DIMENSIONAL FUND ADVISORS LP (72,475 shares), and Connor, Clark & Lunn Investment Management Ltd. (63,945 shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.